JP2000504335A - ビフェニル化合物及びエストロゲン剤としてのその使用 - Google Patents
ビフェニル化合物及びエストロゲン剤としてのその使用Info
- Publication number
- JP2000504335A JP2000504335A JP9527365A JP52736597A JP2000504335A JP 2000504335 A JP2000504335 A JP 2000504335A JP 9527365 A JP9527365 A JP 9527365A JP 52736597 A JP52736597 A JP 52736597A JP 2000504335 A JP2000504335 A JP 2000504335A
- Authority
- JP
- Japan
- Prior art keywords
- group
- compound
- formula
- hydroxy
- biphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/20—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
- C07C205/20—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
- C07C205/26—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups and being further substituted by halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/58—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton the carbon skeleton being further substituted by halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/59—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
- C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/74—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C215/76—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton of the same non-condensed six-membered aromatic ring
- C07C215/78—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton of the same non-condensed six-membered aromatic ring containing at least two hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
- C07C39/15—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/24—Halogenated derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/24—Halogenated derivatives
- C07C39/367—Halogenated derivatives polycyclic non-condensed, containing only six-membered aromatic rings as cyclic parts, e.g. halogenated poly-hydroxyphenylalkanes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/24—Halogenated derivatives
- C07C39/373—Halogenated derivatives with all hydroxy groups on non-condensed rings and with unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
- C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
- C07C45/59—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
- C07C47/56—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing hydroxy groups
- C07C47/57—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing hydroxy groups polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
- C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
- C07C49/83—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups polycyclic
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 一般式(I): {式中、R1及びR2は同一であっても異なっていてもよく、水素原子、ハロゲン 原子、ヒドロキシル基、トリフルオルメチル基、ニトロ基、アミノ基、アルキル オキシ、アルキルチオ、アルキルアミノ若しくはジアルキルアミノ基(ここで、 アルキル基は1〜8個の炭素原子を有する)、−NRARB基(ここで、RA及び RBはそれらが結合している窒素原子と共に五又は六員の飽和又は不飽和複素環 を形成し、この環はN、O及びSから選択される別の複素原子を随意に含有して いてもよい)、多くとも8個の炭素原子を有し且つ随意に置換された直鎖状若し くは分枝鎖状アルキル、アルケニル若しくはアルキニル基、6〜14個の炭素原 子を有し且つ随意に置換されたアリール基、7〜15個の炭素原子を有し且つ随 意に置換されたアルアルキル基又は−CH(OH)−Y若しくは−C(O)−Y基( ここで、Yは1〜8個の炭素原子を有する置換若しくは非置換アルキル、アルケ ニル若しくはアルキニル基又は6〜14個の炭素原子を有する置換若しくは非置 換アリール基を表わす)を表わし、R1はR3と一緒になって−CH=CH−CH =CH−基を形成することもでき、 R3及びR4は同一であっても異なっていてもよく、水素原子、ハロゲン原子又 は1〜8個の炭素原子を有するアルキル基を表わし、R3はR1と一緒になって− CH=CH−CH=CH−基を形成することもでき、 R6及びR7は同一であっても異なっていてもよく、水素原子又はハロゲン原子 を表わし、 R8は水素原子又は随意に置換されたベンジル基を表わし、 R5は−[A]−CH3、−[A]−C(OH)ZZ’又は−[A]−C(O)Z”基(こ こで、−[A]−は多くとも8個の炭素原子を有する直鎖状若しくは分枝鎖状アル キレン、アルケニレン若しくはアルキニレン基又は単結合を表わし、Z、Z’及 びZ”は水素原子、8個までの炭素原子を有し且つ随意に置換されたアルキル、 アルケニル若しくはアルキニル基又は6〜14個の炭素原子を有し且つ随意に置 換されたアリール基を表わす)を表わす} の化合物 (但し、R5が−[A]−C(O)Z”基を表わし、−[A]−が単結合であり、Z” が1〜8個の炭素原子を有するアルキル基であり且つR1、R2、R3、R4、R6 、R7及びR8が水素原子である化合物は除くものとする) 又はその製薬上許容できる酸若しくは塩基付加塩から成る薬剤。 2. 一般式(I’) (式中、各記号は、 (1)R'5が請求項1記載の通りの−[A]−CHO基を表わし且つR1、R2、R3 、R4、R6、R7及びR8が請求項1記載の通りであり、但し、[A]が単結合で あり且つR3、R4、R6、R7及びR8が水素原子である場合にはR1及びR2が同 時に水素原子を表わすことはできない; (2)R'5が請求項1記載の通りの−[A]−C(OH)ZZ’基を表わし且つR1、 R2、R3、R4、R6、R7及びR8が請求項1記載の通りであり、但し、[A]が 単結合であり且つR3、R4、R6、R7及びR8が水素原子である場合にはR1及び R2が同時に水素原子を表わすことはできない; (3)R'5が請求項1記載の通りの−[A]−CH3基を表わし且つR1、R2、R3 、 R4、R6、R7及びR8が請求項1記載の通りであり、但し、R3、R4、R6、R7 及びR8が水素原子である場合にはR1及びR2が同時に水素原子を表わすことは できず、また、R1、R2、R3若しくはR4はアルキル基若しくはハロゲン原子を 表わすことができない; 又は (4)R'5が請求項1記載の通りの−[A]−C(O)Z”基を表わし且つR1、R2 、R3、R4、R6、R7及びR8が請求項1記載の通りであり、但し、[A]が単 結合であり、R3、R4、R6、R7及びR8が水素原子であり且つZ”が1〜8個 の炭素原子を有するアルキル基である場合にはR1及びR2が同時に水素原子を表 わすことはできず、そしてR1及びR2がニトロ若しくはヒドロキシル基を表わす ことはできない: のいずれかである) に相当する請求項1記載の一般式(I)の化合物又はその製薬上許容できる酸若 しくは塩基付加塩から成る薬剤。 3. R1、R2、R3、R4、R6、R7及びR8が請求項2記載の通りであり且つ −[A]−が単結合を表わす請求項2記載の一般式(I')の化合物又はその製薬 上許容できる酸若しくは塩基付加塩から成る薬剤。 4. R'5が−CH2OH基を表わす請求項2又は3記載の一般式(I')の化合 物又はその製薬上許容できる酸若しくは塩基付加塩から成る薬剤。 5. R6、R7及びR8が水素原子である請求項2〜4のいずれかに記載の一般 式(I')の化合物又はその製薬上許容できる酸若しくは塩基付加塩から成る薬 剤。 6. R1及びR2が同一又は異種のハロゲン原子であり且つR3、R4、R6、R7 及びR8が水素原子である請求項2〜5のいずれかに記載の一般式(I')の化合 物又はその製薬上許容できる酸若しくは塩基付加塩から成る薬剤。 7. 一般式(I”):(式中、R'1は6〜14個の炭素原子を有し且つ随意に置換されたアリール基を 表わし、 R'2はハロゲン原子、ニトロ基又はアミノ基を表わす) に相当する請求項1記載の式(I)の化合物又はその製薬上許容できる酸若しく は塩基付加塩から成る薬剤。 8. R'1が3〜16個の炭素原子を有するジアルキルアミノアルキルオキシ基 で置換されたフェニル基を表わす請求項7記載の一般式(I”)の化合物又はそ の製薬上許容できる酸若しくは塩基付加塩から成る薬剤。 9. 名称が ・2,6−ジブロム−4’−ヒドロキシ−(1,1’−ビフェニル)−4−メタ ノール、 ・2,6−ジクロル−4’−ヒドロキシ−(1,1’−ビフェニル)−4−メタ ノール、 ・2,6−ジニトロ−4’−ヒドロキシ−(1,1’−ビフェニル)−4−メタ ノール、 ・、 ・1−[2−クロル−4’−ヒドロキシ−3−メチル−6−(1−メチルエチル )−(1,1’−ビフェニル−4−イル)]−エタノン、 ・2−ブロム−4’−ヒドロキシ−6−ニトロ−(1,1’−ビフェニル)−4 −メタノール、 ・1−[2−クロル−4’−ヒドロキシ−3−メチル−6−(1−メチルエチル )−(1,1’−ビフェニル−4−イル)]−エタノール、 ・4’−ヒドロキシ−2−トリフルオルメチル−(1,1’−ビフェニル)−4 −メタノール、 ・4’−メチル−2’−トリフルオルメチル−(1,1’−ビフェニル)オール 、 ・2,6−ジクロル−4’−ヒドロキシ−(1,1’−ビフェニル)−4−カル ボキサアルデヒド、 ・2−クロル−4’−ヒドロキシ−6−(1−メチルエチル)−(1,1’−ビ フェニル)−4−メタノール、 ・2−クロル−4’−ヒドロキシ−6−トリフルオルメチル−(1,1’−ビフ ェニル)−4−メタノール、 ・2,6−ジクロル−4’−ヒドロキシ−5’−(フェニルメチル)−(1,1 ’−ビフェニル)−4−メタノール、 ・2−ブロム−6−[[4−[2−(ジメチルアミノ)エトキシ]フェニル]ヒ ドロキシメチル]−4’−ヒドロキシ−(1,1’−ビフェニル)−4−メタノ ール、 ・[6−ブロム−4’−ヒドロキシ−4−(ヒドロキシメチル)−(1,1’− ビフェニル)−2−イル]−[4−[2−(ジメチルアミノ)エトキシ]フェニ ル]メタノン、 ・6’−ブロム−4−[2−(ジメチルアミノ)エトキシ]−4”−ヒドロキシ −(1,1’:2’,1”−テルフェニル)−4’−メタノール、 ・4−[2−(ジメチルアミノ)エトキシ]−4”−ヒドロキシ−6’−ニトロ −(1,1’:2’,1”−テルフェニル)−4’−メタノール 又は ・6’−クロル−4,4”−ジヒドロキシ−(1,1’:2’,1”−テルフェ ニル)−4’−メタノール である請求項1記載の一般式(I)の化合物から成る薬剤。 10. 請求項1〜9のいずれかに記載の少なくとも一種の薬剤を活性成分とし て含有する製薬組成物。 11. 請求項2記載の一般式(I')の化合物又はその酸若しくは塩基付加塩 。 12. 請求項3〜6及び9のいずれかに記載の一般式(I')の化合物又はそ の酸若しくは塩基付加塩。 13. 請求項7又は8記載の一般式(I”)の化合物又はその酸若しくは塩基 付加塩。 14. 請求項2又は11記載の式(I')の化合物の製造方法であって、 次式(II): (式中、R1,R2、R3及びR4は請求項2記載の通りであり、 R5Aは請求項2記載のR'5、水素又はエステル化された若しくはされていない −[A]−COOHを表わし、 Xは水素原子、ハロゲン又は−OSO2CF3基を表わす) の化合物に触媒の存在下で次式(III): {式中、R6及びR7は前記の通りであり、 Yは水素原子、ハロゲン、B(OH)2基又はSn(R)3基(ここで、Rは1〜8 個の炭素原子を有するアルキル基を表わす)を表わし、 Pは保護基を表わす} の化合物を作用させて次式(IV):(式中、P、R1、R2、R3、R4、R5A、R6及びR7は前記と同じ意味を有する ) の化合物を得て、 所望ならば又は必要ならば式(I')の化合物を得るために式(IV)の化合物 を次の反応: ・フェノールの脱保護、 ・R8=ベンジルの式(I)の化合物を得るための脱ベンジル及び続いての転位 、 ・R1又はR2が表わすことがあるNO2基のNH2への完全又は部分的還元、 ・R1、R2、R3又はR4が表わすことがあるNH2のBr又はIによる置換、 ・R5Aが水素原子を表わす場合のホルミル化反応、 ・R5Aが表わすことがあるエステル化された−[A]−COOH官能基の還元、 ・鹸化、 ・R5Aが表わすことがある−[A]−CHO基の−[A]−CH2OH基への還元、 ・R5Aが表わすことがある−[A]−CHO基の−[A]−COOH基への酸化、 ・R5Aが表わすことがある−[A]−COOH基のエステル化、 ・R5Aが表わすことがあるアシル官能基の対応するアルコール又は対応するアル キル基への還元、 ・R5Aが表わすことがある−[A]−CHO官能基に対する−[A]−CH=CH− CHO基を得るためのウィッティヒ(Wittig)反応及び続いての式−[A]−CH =CH−CH2OHの対応するアルコールを得るための不飽和アルデヒドの還元 、 ・R5Aが表わすことがある−[A]−CHO官能基に対する−[A]−CH2−CH O基を得るためのウィッティヒ反応及び続いての式−[A]−CH2−CH2OHの 対応するアルコールを得るための−[A]−CH2−CHOアルデヒドの還元、 ・[A]がアルケニレン又はアルキニレン二価基を表わす場合の還元反応、 ・R5Aが表わすことがあるアルデヒド、ケトン又はエステル化された酸に対する 有機金属の作用、 ・NH2からのピロール基の形成、 ・NH2のS−アルキル基による置換 並びに ・酸又は塩基による塩形成 の一つ又は適宜にいくつかに適宜順序で付す ことを特徴とする、前記方法。 15. 請求項7、8及び13のいずれかに記載の式(I”)の化合物の製造方 法であって、 次式(V): (式中、R'1は請求項7記載の通りであり、 P’は1〜4個の炭素原子を有するアルキル基を表わす) の化合物に次式(VI): (式中、Alk’は1〜4個の炭素原子を有するアルキル基を表わし、 R'2は請求項7記載の通りである) の化合物を作用させて請求項14記載の式(IV)の化合物に対応する次式(VII ):(式中、Alk’、P’、R'1及びR'2は前記の通りである) の化合物を得て、 次いでこの式(VII)の化合物にヒドロキシ官能基の脱保護剤及びエステル官 能基の還元剤を作用させて式(I”)の化合物を得て、次いで所望ならば塩基又 は酸を作用させて対応する塩を得る ことを特徴とする、前記方法。 16. 新規の工業製品としての一般式(IV)の化合物(式(IV)においてR5A がエステル化された又はされていない−[A]−COOH基を表わす化合物を除く )。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR96/01211 | 1996-02-01 | ||
FR9601211A FR2744445B1 (fr) | 1996-02-01 | 1996-02-01 | Composes biphenyles nouveaux et/ou a titre de medicament, compositions pharmaceutiques les contenant, leur procede de preparation et les intermediaires de ce procede |
PCT/FR1997/000183 WO1997027846A1 (fr) | 1996-02-01 | 1997-01-30 | Composes biphenyles et leur utilisation comme agents estrogeniques |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010191192A Division JP5469567B2 (ja) | 1996-02-01 | 2010-08-27 | ビフェニル化合物及びエストロゲン剤としてのその使用 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2000504335A true JP2000504335A (ja) | 2000-04-11 |
JP4634543B2 JP4634543B2 (ja) | 2011-02-16 |
Family
ID=9488724
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP52736597A Expired - Fee Related JP4634543B2 (ja) | 1996-02-01 | 1997-01-30 | ビフェニル化合物及びエストロゲン剤としてのその使用 |
JP2010191192A Expired - Lifetime JP5469567B2 (ja) | 1996-02-01 | 2010-08-27 | ビフェニル化合物及びエストロゲン剤としてのその使用 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010191192A Expired - Lifetime JP5469567B2 (ja) | 1996-02-01 | 2010-08-27 | ビフェニル化合物及びエストロゲン剤としてのその使用 |
Country Status (8)
Country | Link |
---|---|
US (3) | US6288126B1 (ja) |
EP (1) | EP0877607B1 (ja) |
JP (2) | JP4634543B2 (ja) |
AT (1) | ATE345117T1 (ja) |
DE (1) | DE69736945T2 (ja) |
ES (1) | ES2277353T3 (ja) |
FR (1) | FR2744445B1 (ja) |
WO (1) | WO1997027846A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007503466A (ja) * | 2003-05-16 | 2007-02-22 | ワイス | アリール−カルボアルデヒドオキシム誘導体およびエストロゲン様物質としてのその使用 |
JP2014527047A (ja) * | 2011-08-04 | 2014-10-09 | カロ バイオ アクチェブラーグ | 新規なエストロゲン受容体リガンド |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2744445B1 (fr) * | 1996-02-01 | 1998-10-02 | Roussel Uclaf | Composes biphenyles nouveaux et/ou a titre de medicament, compositions pharmaceutiques les contenant, leur procede de preparation et les intermediaires de ce procede |
DE19826213A1 (de) * | 1998-06-09 | 1999-12-16 | Schering Ag | Neue Antiestrogene, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung |
EP1808429A3 (en) * | 2003-05-02 | 2007-10-31 | Wyeth a Corporation of the State of Delaware | Hydroxy-biphenyl-carbaldehyde oxime derivatives and their use as estrogenic agents |
US7279600B2 (en) * | 2003-05-02 | 2007-10-09 | Wyeth | Hydroxy-biphenyl-carbaldehyde oxime derivatives and their use as estrogenic agents |
AU2004251176A1 (en) * | 2003-05-31 | 2005-01-06 | Janssen Pharmaceutica, N.V. | Cyclohexyl derivatives as selective estrogen receptor modulators |
WO2006073726A2 (en) * | 2004-12-31 | 2006-07-13 | Aventis Pharmaceuticals Inc. | Use of certain biphenyl compounds for protection of neurons and oligodendrocytes in the treatment of multiple sclerosis (ms) |
US20070066628A1 (en) * | 2005-09-19 | 2007-03-22 | Wyeth | 5-Aryl-indan-1-ol and analogs useful as progesterone receptor modulators |
US7319152B2 (en) * | 2005-09-19 | 2008-01-15 | Wyeth | 5-Aryl-indan-1-one and analogs useful as progesterone receptor modulators |
US7414142B2 (en) * | 2005-09-19 | 2008-08-19 | Wyeth | 5-aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators |
CN107474038B (zh) * | 2017-07-17 | 2020-10-09 | 苏州楚凯药业有限公司 | 一类靶向雌激素受体荧光探针及其制备和使用方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4961144A (ja) * | 1972-06-15 | 1974-06-13 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02296247A (ja) * | 1989-05-11 | 1990-12-06 | Nippon Zeon Co Ltd | ボジ型レジスト組成物 |
US5218124A (en) * | 1989-10-27 | 1993-06-08 | American Home Products Corporation | Substituted benzoylbenzene-, biphenyl- and 2-oxazole-alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase |
JPH0532579A (ja) * | 1991-08-01 | 1993-02-09 | Banyu Pharmaceut Co Ltd | エストロゲン物質be−25327及びその製造法 |
FR2737721B1 (fr) * | 1995-08-08 | 1997-09-05 | Roussel Uclaf | Nouveaux composes biphenyles, leur procede de preparation et les intermediaires de ce procede, leur application a titre de medicament et les compositions pharmaceutiques les contenant |
FR2744445B1 (fr) * | 1996-02-01 | 1998-10-02 | Roussel Uclaf | Composes biphenyles nouveaux et/ou a titre de medicament, compositions pharmaceutiques les contenant, leur procede de preparation et les intermediaires de ce procede |
-
1996
- 1996-02-01 FR FR9601211A patent/FR2744445B1/fr not_active Expired - Fee Related
-
1997
- 1997-01-30 EP EP97902407A patent/EP0877607B1/fr not_active Expired - Lifetime
- 1997-01-30 WO PCT/FR1997/000183 patent/WO1997027846A1/fr active IP Right Grant
- 1997-01-30 US US09/117,628 patent/US6288126B1/en not_active Expired - Lifetime
- 1997-01-30 ES ES97902407T patent/ES2277353T3/es not_active Expired - Lifetime
- 1997-01-30 JP JP52736597A patent/JP4634543B2/ja not_active Expired - Fee Related
- 1997-01-30 AT AT97902407T patent/ATE345117T1/de not_active IP Right Cessation
- 1997-01-30 DE DE69736945T patent/DE69736945T2/de not_active Expired - Lifetime
-
2001
- 2001-06-29 US US09/896,943 patent/US6563008B2/en not_active Expired - Fee Related
-
2002
- 2002-07-08 US US10/190,497 patent/US6794415B2/en not_active Expired - Fee Related
-
2010
- 2010-08-27 JP JP2010191192A patent/JP5469567B2/ja not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4961144A (ja) * | 1972-06-15 | 1974-06-13 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007503466A (ja) * | 2003-05-16 | 2007-02-22 | ワイス | アリール−カルボアルデヒドオキシム誘導体およびエストロゲン様物質としてのその使用 |
JP2014527047A (ja) * | 2011-08-04 | 2014-10-09 | カロ バイオ アクチェブラーグ | 新規なエストロゲン受容体リガンド |
Also Published As
Publication number | Publication date |
---|---|
JP2010270150A (ja) | 2010-12-02 |
DE69736945T2 (de) | 2007-12-06 |
EP0877607B1 (fr) | 2006-11-15 |
JP4634543B2 (ja) | 2011-02-16 |
EP0877607A1 (fr) | 1998-11-18 |
ES2277353T3 (es) | 2007-07-01 |
DE69736945D1 (de) | 2006-12-28 |
ATE345117T1 (de) | 2006-12-15 |
US6563008B2 (en) | 2003-05-13 |
FR2744445A1 (fr) | 1997-08-08 |
JP5469567B2 (ja) | 2014-04-16 |
US6288126B1 (en) | 2001-09-11 |
US6794415B2 (en) | 2004-09-21 |
FR2744445B1 (fr) | 1998-10-02 |
US20040043993A1 (en) | 2004-03-04 |
US20020068736A1 (en) | 2002-06-06 |
WO1997027846A1 (fr) | 1997-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5469567B2 (ja) | ビフェニル化合物及びエストロゲン剤としてのその使用 | |
EP1257264B1 (en) | Estrogen receptor modulators | |
JPS6122046A (ja) | スチルベン誘導体 | |
Jones et al. | Synthesis and antiestrogenic activity of [3, 4-dihydro-2-(4-methoxyphenyl)-1-naphthalenyl][4-[2-(1-pyrrolidinyl) ethoxy] phenyl] methanone, methanesulfonic acid salt | |
JPS6332777B2 (ja) | ||
JPH01157934A (ja) | 新規なベンゾシクロヘプテン誘導体 | |
US6147119A (en) | Biphenyl compounds and use thereof as oestrogenic agents | |
Elfehail et al. | . alpha.-Nitro ketones. 5. Synthesis of 2-nitrocyclopentanones | |
JP4035332B2 (ja) | シクロヘキセノン長鎖アルコールの製造法 | |
JPS637174B2 (ja) | ||
US6448294B1 (en) | Biphenyl compounds and their use as oestrogenic agents | |
JP2003502300A (ja) | 1−(3,5−ビス(トリフルオロメチル)−フェニル)エタン−1−オンの合成プロセス | |
US7235700B2 (en) | Process for producing cyclohexenone long-chain alcohols | |
JPH0466219B2 (ja) | ||
JPS6045191B2 (ja) | 新しい抗受精剤 | |
Kamikawa et al. | Reaction of 2, 6-dimethyl-4-methoxybenzaldehyde with methylmagnesium iodide and some properties of the reaction products | |
NO742801L (ja) | ||
WO1997043235A1 (fr) | Derives polyhydroxyphenols et agents les contenant, destines a la prevention et a la therapie de maladies de l'os et du cartilage | |
Grigsby | Applications of σ-organomanganese compounds in the synthesis of potential antitumour agents | |
Shachat | Grignard Reagents Containing an Hindered Carbonyl Function | |
JPS617229A (ja) | α−ヒドロキシケトン誘導体の製造方法 | |
JPH0899980A (ja) | トリフラート化合物及びそれを用いたシラシクロヘキサン型液晶化合物の製造方法 | |
JPS6259688B2 (ja) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040123 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080115 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20080201 |
|
RD13 | Notification of appointment of power of sub attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7433 Effective date: 20080201 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080411 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080526 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080715 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20081014 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090109 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090216 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090414 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100427 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100827 Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20100827 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100827 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20101014 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20101026 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20101119 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131126 Year of fee payment: 3 |
|
LAPS | Cancellation because of no payment of annual fees |